These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37385631)

  • 41. Haemophagocytic lymphohistiocytosis in human immunodeficiency virus: a systematic review of literature.
    Fazal F; Gupta N; Mittal A; Ray A
    Drug Discov Ther; 2020 Nov; 14(5):226-231. PubMed ID: 33116036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved hemophagocytic lymphohistiocytosis index predicts prognosis of adult Epstein-Barr virus-associated HLH patients.
    Yao S; He L; Zhang R; Liu M; Hua Z; Zou H; Wang Z; Wang Y
    Ann Med; 2023 Dec; 55(1):89-100. PubMed ID: 36533966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case report.
    Yan WL; Yang SL; Zhao FY; Xu XJ
    J Oncol Pharm Pract; 2022 Jan; 28(1):222-227. PubMed ID: 34074166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Etoposide-containing conditioning regimen reduces the occurrence of hemophagocytic lymphohistiocytosis after SCT.
    Kobayashi R; Tanaka J; Hashino S; Ota S; Torimoto Y; Kakinoki Y; Yamamoto S; Kurosawa M; Hatakeyama N; Haseyama Y; Sakai H; Sato K; Fukuhara T
    Bone Marrow Transplant; 2014 Feb; 49(2):254-7. PubMed ID: 24037021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of hemophagocytic lymphohistiocytosis in patients in the intensive care unit].
    Eichenauer DA; La Rosée P
    Inn Med (Heidelb); 2023 Oct; 64(10):955-960. PubMed ID: 37702780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Case of Hemophagocytic Lymphohistiocytosis following Second Dose of COVID-19 Vaccination.
    Park HW; Min GJ; Kim TY; Cho SG
    Acta Haematol; 2023; 146(1):65-71. PubMed ID: 36096118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of pediatric primary hemophagocytic lymphohistiocytosis with the HLH-94/2004 regimens and hematopoietic stem cell transplantation in China.
    Ma H; Zhang R; Zhang L; Wei A; Zhao X; Yang Y; Liu W; Li Z; Qin M; Wang T
    Ann Hematol; 2020 Oct; 99(10):2255-2263. PubMed ID: 32766934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recommendations for the Use of Etoposide-Based Therapy and Bone Marrow Transplantation for the Treatment of HLH: Consensus Statements by the HLH Steering Committee of the Histiocyte Society.
    Ehl S; Astigarraga I; von Bahr Greenwood T; Hines M; Horne A; Ishii E; Janka G; Jordan MB; La Rosée P; Lehmberg K; Machowicz R; Nichols KE; Sieni E; Wang Z; Henter JI
    J Allergy Clin Immunol Pract; 2018; 6(5):1508-1517. PubMed ID: 30201097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spontaneous Recovery of Hemophagocytic Lymphohistiocytosis Due to Primary Epstein-Barr Virus Infection in an Adult Patient.
    Matsuo Y; Iwanami K; Hiraoka E; Oda R
    Am J Case Rep; 2021 Oct; 22():e933272. PubMed ID: 34657119
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of the JAK Inhibitor Ruxolitinib in the Treatment of Hemophagocytic Lymphohistiocytosis.
    Keenan C; Nichols KE; Albeituni S
    Front Immunol; 2021; 12():614704. PubMed ID: 33664745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemophagocytic lymphohistiocytosis associated with acute otitis media: A case report.
    Chung DH; Lee KY; Kim JY; Jung DJ
    Medicine (Baltimore); 2024 Jun; 103(25):e38616. PubMed ID: 38905364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Dog saliva causes rare and life-threatening infection].
    Dooijes R; Fourmanov RS; Jonkers F; Nieuwenhuizen L; Geerets F; de Lil HS
    Ned Tijdschr Geneeskd; 2022 Jan; 166():. PubMed ID: 35129896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dilemmas in diagnosis and management of hemophagocytic lymphohistiocytosis in children.
    Xu XJ; Tang YM
    World J Pediatr; 2020 Aug; 16(4):333-340. PubMed ID: 31506890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent advances in the treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.
    Jesudas R; Nichols KE
    Curr Opin Allergy Clin Immunol; 2022 Dec; 22(6):364-370. PubMed ID: 36206094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Requirement for etoposide in the treatment of pregnancy related hemophagocytic lymphohistiocytosis: a multicenter retrospective study.
    Song Y; Wang Z; Hao Z; Li L; Lu J; Kang H; Lu Y; You Y; Li L; Chen Q; Chen B
    Orphanet J Rare Dis; 2019 Feb; 14(1):50. PubMed ID: 30777105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
    Hu S; Bansal P; Lynch D; Rojas Hernandez CM; Dayao Z
    J Med Case Rep; 2016 Dec; 10(1):365. PubMed ID: 27998299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe anaplasmosis represents a treatable cause of secondary hemophagocytic lymphohistiocytosis: Two cases and review of literature.
    Rocco JM; Mallarino-Haeger C; McCurry D; Shah N
    Ticks Tick Borne Dis; 2020 Sep; 11(5):101468. PubMed ID: 32723647
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How can an internal medicine specialist save a patient with hemophagocytic lymphohistiocytosis (HLH)?
    Machowicz R; Basak G
    Pol Arch Intern Med; 2020 May; 130(5):431-437. PubMed ID: 32134401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Central nervous system involvement in adult-onset relapsing hemophagocytic lymphohistiocytosis responsive to maintenance treatment with anakinra.
    Hiraldo JDG; Domínguez-Mayoral A; García-Gómez FJ; Fouz-Rosón N; Rivas-Infante E; Cano MAM; Fernández AR; Morillo SG; Fernández NA; de León JAP; Mascarell GN; Lebrón CV
    J Neuroimmunol; 2021 Jun; 355():577552. PubMed ID: 33845282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report.
    Meazza Prina M; Martini F; Bracchi F; Di Mauro D; Fargnoli A; Motta M; Giussani C; Gobbin G; Taverna M; D'Alessio A
    BMC Infect Dis; 2021 Aug; 21(1):811. PubMed ID: 34388982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.